[go: up one dir, main page]

NO20014805L - Blandinger og fremgangsmater for behandling og diagnose av brystkreft - Google Patents

Blandinger og fremgangsmater for behandling og diagnose av brystkreft

Info

Publication number
NO20014805L
NO20014805L NO20014805A NO20014805A NO20014805L NO 20014805 L NO20014805 L NO 20014805L NO 20014805 A NO20014805 A NO 20014805A NO 20014805 A NO20014805 A NO 20014805A NO 20014805 L NO20014805 L NO 20014805L
Authority
NO
Norway
Prior art keywords
mixtures
treating
methods
breast cancer
diagnosing breast
Prior art date
Application number
NO20014805A
Other languages
English (en)
Other versions
NO20014805D0 (no
Inventor
Steven G Reed
John M Smith
Tony N Frudakis
Davin C Dillon
Lynda E Misher
Marc W Retter
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/289,198 external-priority patent/US6586570B1/en
Priority claimed from US09/429,755 external-priority patent/US6656480B2/en
Priority claimed from US09/534,825 external-priority patent/US6861506B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20014805D0 publication Critical patent/NO20014805D0/no
Publication of NO20014805L publication Critical patent/NO20014805L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20014805A 1999-04-09 2001-10-03 Blandinger og fremgangsmater for behandling og diagnose av brystkreft NO20014805L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/289,198 US6586570B1 (en) 1996-01-11 1999-04-09 Compositions and methods for the treatment and diagnosis of breast cancer
US09/429,755 US6656480B2 (en) 1996-01-11 1999-10-28 Compositions and methods for the treatment and diagnosis of breast cancer
US09/534,825 US6861506B1 (en) 1996-01-11 2000-03-23 Compositions and methods for the treatment and diagnosis of breast cancer
PCT/US2000/009312 WO2000061753A2 (en) 1999-04-09 2000-04-07 Compositions and methods for the treatment and diagnosis of breast cancer

Publications (2)

Publication Number Publication Date
NO20014805D0 NO20014805D0 (no) 2001-10-03
NO20014805L true NO20014805L (no) 2001-12-06

Family

ID=27403868

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014805A NO20014805L (no) 1999-04-09 2001-10-03 Blandinger og fremgangsmater for behandling og diagnose av brystkreft

Country Status (15)

Country Link
EP (1) EP1169444A2 (no)
JP (1) JP2002541803A (no)
KR (1) KR20020026418A (no)
CN (1) CN1352683A (no)
AU (1) AU774824B2 (no)
BR (1) BR0009573A (no)
CA (1) CA2365909A1 (no)
CZ (1) CZ20013575A3 (no)
HU (1) HUP0200825A2 (no)
IL (1) IL145719A0 (no)
MX (1) MXPA01010186A (no)
NO (1) NO20014805L (no)
NZ (1) NZ514646A (no)
PL (1) PL350863A1 (no)
WO (1) WO2000061753A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
CN111983220B (zh) * 2019-05-21 2024-03-19 北京中科纳泰生物科技有限公司 多肽磁性纳米颗粒、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025431A1 (en) * 1996-01-10 1997-07-17 Corixa Corporation Compositions and methods for the treatment and diagnosis of cancer
EP1876241A3 (en) * 1996-01-11 2008-07-30 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
WO1999031236A2 (en) * 1997-12-17 1999-06-24 Genset EXTENDED cDNAs FOR SECRETED PROTEINS
CZ2001149A3 (cs) * 1998-07-14 2002-02-13 Corixa Corporation Prostředky a způsoby pro terapii a diagnostiku karcinomu prostaty

Also Published As

Publication number Publication date
WO2000061753A3 (en) 2001-06-28
AU774824B2 (en) 2004-07-08
CA2365909A1 (en) 2000-10-19
PL350863A1 (en) 2003-02-10
KR20020026418A (ko) 2002-04-10
HUP0200825A2 (en) 2002-07-29
EP1169444A2 (en) 2002-01-09
NZ514646A (en) 2005-04-29
NO20014805D0 (no) 2001-10-03
MXPA01010186A (es) 2004-08-12
JP2002541803A (ja) 2002-12-10
CZ20013575A3 (cs) 2002-10-16
AU4213000A (en) 2000-11-14
WO2000061753A2 (en) 2000-10-19
BR0009573A (pt) 2002-04-16
IL145719A0 (en) 2002-07-25
CN1352683A (zh) 2002-06-05

Similar Documents

Publication Publication Date Title
NO20013002D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
NO20030714D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av HER-2/NEU-assosierte maligniteter
NO20024972L (no) Blandinger og fremgangsmater for terapi og diagnose av brystkreft
NO20010196D0 (no) Sammensetninger og fremgangsmåter for terapi og diagnose av prostatakreft
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO20014769D0 (no) Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav
EP1161680A4 (en) METHOD FOR DIAGNOSTICING AND MONITORING Malignant Breast Carcinomas
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
EP1239874A4 (en) METHOD OF DIAGNOSIS, MONITORING, CLASSIFICATION, IMAGINATION AND TREATMENT OF PROSTATE CANCER
NO20022592L (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
NO996253D0 (no) Diagnostiske midler og legemidler for maligne tumorer
EP1082459A4 (en) NEW METHOD FOR DIAGNOSING, MONITORING AND DETERMINING THE STAGE OF LUNG CANCER
DK1091D0 (da) Immunkonjugater til diagnose og behandling af cancer
FI990559A0 (fi) Näytteenkäsittelymenetelmä ja diagnostinen mittauslaite
EP1175616A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT OF METASTATIC PROSTATATORS
AU2001250932A8 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
DE69921223D1 (de) Entwicklungsapparat, Apparate-Einheit und Bilderzeugungsverfahren
LU90157B1 (fr) Méthodes de prévention du cancer du sein
NO20014804L (no) Forbindelser for immunterapi og diagnose av brystkreft og fremgangsmåter for deres anvendelse
IL142340A0 (en) Methods for identification, diagnosis, and treatment of breast cancer
NO20014805L (no) Blandinger og fremgangsmater for behandling og diagnose av brystkreft
EP1267934A4 (en) NEW METHOD OF DIAGNOSIS, MONITORING, STATUS ASSESSMENT, IMAGE AND TREATMENT OF BREAST CANCER
NO20025594L (no) Blandinger og fremgangsmåter for terapi og diagnose av brystkreft

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application